Supadopa TR Capsule 48.75 mg + 195 mg is a combination of Levodopa and Carbidopa in an extended-release (TR) formulation, designed for the treatment of Parkinson’s disease. Parkinson’s disease is a progressive neurological disorder characterized by tremors, muscle stiffness, slow movement (bradykinesia), and impaired balance. The extended-release design provides a gradual release of medication, maintaining stable dopamine levels in the brain and minimizing fluctuations in motor symptoms throughout the day.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Uses and Benefits

• Parkinson’s Disease Management: Effectively reduces tremors, rigidity, bradykinesia, and postural instability.

• Extended Symptom Control: TR formulation ensures steady dopamine levels, reducing “off” periods and improving daily functioning.

• Combination Therapy: Carbidopa prevents the premature breakdown of Levodopa in the bloodstream, increasing the amount that reaches the brain and minimizing side effects like nausea.

• Improved Quality of Life: Supports mobility, independence, and functional ability for patients with Parkinson’s disease.

Mechanism of Action

• Levodopa: Converts into dopamine in the brain, replenishing the depleted neurotransmitter necessary for movement control.

• Carbidopa: Inhibits peripheral conversion of Levodopa to dopamine, enhancing the drug’s effectiveness and reducing gastrointestinal side effects.

• Extended-Release (TR): Provides a controlled release of the active ingredients, maintaining stable dopamine levels and consistent symptom management.

Dosage and Administration

• Administration: Take orally with water. Capsules should be swallowed whole; do not crush, chew, or break.

• Timing: Can be taken with or without food. Avoid high-protein meals, which may interfere with absorption.

• Dosage: Individualized according to disease severity and patient response. Typically administered 1–2 times daily as directed by a healthcare professional.

• Monitoring: Regular follow-up with a neurologist is recommended to adjust dosing and monitor treatment response.

Precautions and Safety Information

• Medical History: Inform your doctor if you have heart disease, kidney or liver problems, glaucoma, psychiatric conditions, or history of ulcers.

• Pregnancy and Lactation: Use only under medical supervision.

• Drug Interactions: Avoid non-selective MAO inhibitors and certain antipsychotics. Always inform your doctor about all medications being taken.

• Activity Caution: May cause dizziness or drowsiness; avoid driving or operating machinery until you know how it affects you.

Possible Side Effects

Supadopa TR Capsule is generally well tolerated. Possible side effects may include:

• Nausea, vomiting, or loss of appetite

• Dizziness or lightheadedness

• Dyskinesia (involuntary movements)

• Sleep disturbances, vivid dreams, or confusion

• Rarely, low blood pressure or psychiatric symptoms

Side effects are often minimized by proper dose adjustment and adherence to the prescribed schedule.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a cool, dry place.

• Protect from light and moisture.

• Keep out of reach of children.

Supadopa TR Capsule 48.75 mg + 195 mg offers an effective, extended-release option for Parkinson’s disease management, providing consistent symptom control, improved motor function, and enhanced daily quality of life under proper medical supervision.